Source: Ohio Department of Health
The Centers for Disease Control and Prevention’s (CDC) National Center for HIV, Viral Hepatitis, STD, and TB Prevention has issued several recommended actions for physicians and other healthcare professionals following a new voluntary recall by a subsidiary of Pfizer for specific referenced lots of Bicillin® L-A (Penicillin G Benzathine Injectable Suspension).
Penicillin is the only recommended treatment for pregnant women and babies with congenital syphilis. Considering this recall and high levels of syphilis diagnoses in the United States, the CDC anticipates a limited supply of Bicillin® L-A and recommends preserving Bicillin® L-A for treating patients who are pregnant until more is learned about the impact of the recall given the dynamic nature of the situation.
More information, including CDC’s recommended actions, visit the CDC website.